What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®

Agnès Sommet¹, Justine Bénévent¹, Vanessa Rousseau¹, Leila Chebane¹, Antonios Douros^{2

3

4}, Jean-Louis Montastruc¹, François Montastruc^{5

6}

Affiliations

¹ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, France.
² Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.
³ Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada.
⁴ Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
⁵ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, France. francois.montastruc@mail.mcgill.ca.
⁶ Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada. francois.montastruc@mail.mcgill.ca.

Agnès Sommet et al. J Gen Intern Med. 2019 Apr.

. 2019 Apr;34(4):502-503.

doi: 10.1007/s11606-018-4774-2.

Agnès Sommet¹, Justine Bénévent¹, Vanessa Rousseau¹, Leila Chebane¹, Antonios Douros^{2

3

4}, Jean-Louis Montastruc¹, François Montastruc^{5

6}

¹ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, France.
² Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.
³ Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada.
⁴ Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
⁵ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, France. francois.montastruc@mail.mcgill.ca.
⁶ Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada. francois.montastruc@mail.mcgill.ca.

No abstract available

Keywords: aortic aneurysms; aortic dissection; fluoroquinolones; levofloxacin.

Conflict of interest statement

The authors declare that they do not have a conflict of interest.

1. Daneman N, Lu H, Redelmeier DA. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open 2015 18;5(11):e010077. - PMC - PubMed
1. Lee CC, Lee MT, Chen YS, Lee SH, Chen YS, Chen SC, Chang SC. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone. JAMA Intern Med. 2015;175:1839–47. doi: 10.1001/jamainternmed.2015.5389. - DOI - PubMed
1. Pasternak B, Inghammar M, Svanström H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018;360:k678. doi: 10.1136/bmj.k678. - DOI - PMC - PubMed
1. Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72(6):905–8. doi: 10.1111/j.1365-2125.2011.04037.x. - DOI - PMC - PubMed
1. Pierfitte C, Bégaud B, Lagnaoui R. Moore ND. Is reporting rate a good predictor of risks associated with drugs? Br J Clin Pharmacol. 1999;47:329–31. doi: 10.1046/j.1365-2125.1999.00881.x. - DOI - PMC - PubMed